Contact
searchSearch
HMP Global

Nephropathy

News
Pharmacist-Led Outreach Boosts SGLT2 Inhibitor Initiation in Veterans With CKD and Diabetes
06/05/2026
Grace Taylor, MS, MA
Clinical pharmacists nearly doubled SGLT2 inhibitor initiation among veterans with chronic kidney disease (CKD) and type 2 diabetes in a large US Department of Veterans Affairs quality improvement study.
Clinical pharmacists nearly doubled SGLT2 inhibitor initiation among veterans with chronic kidney disease (CKD) and type 2 diabetes in a large US Department of Veterans Affairs quality improvement study.
Clinical pharmacists nearly...
06/05/2026
First Report Managed Care
Nephrology, kidney disease
Managed Care Insights
The Evolving Nephrology Landscape: Treatment, Innovation, and Policy: Part 3
05/29/2026
Suzanne Watnick, MD
Suzanne Watnick, MD, explains why earlier chronic kidney disease detection, broader access to proven therapies, and reimbursement policies that support innovation are critical to improving kidney care outcomes and reducing progression to...
Suzanne Watnick, MD, explains why earlier chronic kidney disease detection, broader access to proven therapies, and reimbursement policies that support innovation are critical to improving kidney care outcomes and reducing progression to...
Suzanne Watnick, MD, explains...
05/29/2026
First Report Managed Care
Nephrology, kidney disease
Managed Care Insights
The Evolving Nephrology Landscape: Treatment, Innovation, and Policy: Part 2
05/29/2026
Suzanne Watnick, MD
Dr Suzanne Watnick examines how greater investment, equitable policies, and stakeholder collaboration will be essential to ensuring that emerging kidney therapies improve outcomes without widening existing disparities in care.
Dr Suzanne Watnick examines how greater investment, equitable policies, and stakeholder collaboration will be essential to ensuring that emerging kidney therapies improve outcomes without widening existing disparities in care.
Dr Suzanne Watnick examines how...
05/29/2026
First Report Managed Care
Nephrology, kidney disease
Managed Care Insights
The Evolving Nephrology Landscape: Treatment, Innovation, and Policy
05/29/2026
Suzanne Watnick, MD
Dr Suzanne Watnick explains how value-based kidney care can improve outcomes by shifting focus upstream to earlier chronic kidney disease intervention, prevention, and long-term cost savings.
Dr Suzanne Watnick explains how value-based kidney care can improve outcomes by shifting focus upstream to earlier chronic kidney disease intervention, prevention, and long-term cost savings.
Dr Suzanne Watnick explains how...
05/29/2026
First Report Managed Care
News
BeWell360-CKD Model Targets Whole-Person Kidney Care Transformation
04/06/2026
Hannah Musick
The BeWell360-CKD model proposes a whole-person, value-based approach to kidney care that integrates lifestyle, behavioral, and supportive interventions to reduce treatment burden and improve patient outcomes.
The BeWell360-CKD model proposes a whole-person, value-based approach to kidney care that integrates lifestyle, behavioral, and supportive interventions to reduce treatment burden and improve patient outcomes.
The BeWell360-CKD model proposes...
04/06/2026
First Report Managed Care
News
Large Language Model Shows Promise for Nephrology Prior Authorization Letter Drafting
04/06/2026
Hannah Musick
ChatGPT-5 generated largely accurate, guideline-aligned prior authorization letters in nephrology but still required clinician oversight due to gaps in coding precision and citation reliability, according to a study published in Frontiers in...
ChatGPT-5 generated largely accurate, guideline-aligned prior authorization letters in nephrology but still required clinician oversight due to gaps in coding precision and citation reliability, according to a study published in Frontiers in...
ChatGPT-5 generated largely...
04/06/2026
First Report Managed Care
News
Multidrug Therapy Has Redefined Kidney Protection in Diabetic Kidney Disease
03/18/2026
Lisa Kuhns, PhD, MD
Decades of clinical trials are reshaping diabetic kidney disease care, with combination therapies now delivering unprecedented gains in renal and cardiovascular outcomes.
Decades of clinical trials are reshaping diabetic kidney disease care, with combination therapies now delivering unprecedented gains in renal and cardiovascular outcomes.
Decades of clinical trials are...
03/18/2026
First Report Managed Care
Industry Insights
News

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use